ArticleFunctional & integrative genomics2026
Whole-genome and Comparative Genomic Analysis Reveal the Biocontrol and Plant Growth-Promoting Potential of Bacillus velezensis JN.Y2 Against Oat Anthracnose.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Oat anthracnose, primarily caused by Colletotrichum cereale, represents a significant threat to oat production, necessitating the development of sustainable biocontrol alternatives. In this study, we characterized an oat endophytic bacterium, Bacillus velezensis JN.Y2, isolated from healthy oat leaves in Inner Mongolia. In vitro assays demonstrated that B. velezensis JN.Y2 (designated as Bv. JN.Y2) possesses an inhibitory activity against C. cereale (74.49%) and exhibits a broad antifungal spectrum. Greenhouse and three-year multi-location field trials confirmed its beneficial biocontrol efficacy, which remained stable even under fluctuating climatic conditions and high disease pressure, consistently outperforming conventional chemical treatments. Beyond disease suppression, Bv. JN.Y2 significantly enhanced oat growth and grain yield, supported by its ability to produce IAA, solubilize nutrients, and secrete diverse hydrolytic enzymes. Complete genome sequencing revealed a 3.87 Mb circular chromosome containing 13 secondary metabolite BGCs and 4 AOIs for RiPPs, including Amylocyclicin and LCI. Comparative genomic analysis highlighted an "open" pangenome and identified 411 unique genes associated with specialized metabolism and environmental sensing. While Bv. JN.Y2 shares high sequence synteny with B. velezensis CBMB205, distinct variations in the sporulation kinase kinA and secondary metabolite pathways suggest a fine-tuned adaptation to the oat endosphere. Furthermore, biosafety evaluations confirmed a relatively high level of genetic stability and a lack of active antibiotic resistance. Collectively, these findings provide a beneficial molecular foundation for the application of Bv. JN.Y2 as a reliable and secure biocontrol agent in sustainable agriculture.
Indexed as
Identifiers
42360518What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.